{"transactions":[{"id":692504,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":25235,"kind":"person","name":"Hensley Mark Earl","position":1,"cik":"0002065816","reported_name":"Hensley Mark Earl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-10T14:18:44.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest with 25% upon the first anniversary of date of grant (May 6, 2025) and then in twelve (12) equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest with 25% upon the first anniversary of date of grant (May 6, 2025) and then in twelve (12) equal quarterly installments thereafter."}],"balance_after":343750,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001193125-26-341528","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526341528/ownership.xml","form_type":"4"}},{"id":692503,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":25235,"kind":"person","name":"Hensley Mark Earl","position":1,"cik":"0002065816","reported_name":"Hensley Mark Earl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-08-10T14:18:44.000Z","date":"2026-08-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":8888,"price":0.5,"value":4444.0,"ownership":{"direct":true},"balance_after":170901,"source":{"system":"sec-edgar","filing":"0001193125-26-341528","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526341528/ownership.xml","form_type":"4"}},{"id":692502,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":25235,"kind":"person","name":"Hensley Mark Earl","position":1,"cik":"0002065816","reported_name":"Hensley Mark Earl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-08-10T14:18:44.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":31250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":179789,"source":{"system":"sec-edgar","filing":"0001193125-26-341528","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526341528/ownership.xml","form_type":"4"}},{"id":699418,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":25235,"kind":"person","name":"Hensley Mark Earl","position":1,"cik":"0002065816","reported_name":"Hensley Mark Earl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-03T15:20:56.000Z","date":"2026-07-31","kind":"exercise","planned":false,"acquired":false,"shares":11769,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."}],"balance_after":164776,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11769},"source":{"system":"sec-edgar","filing":"0001193125-26-329848","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329848/ownership.xml","form_type":"4"}},{"id":699417,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":25235,"kind":"person","name":"Hensley Mark Earl","position":1,"cik":"0002065816","reported_name":"Hensley Mark Earl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-08-03T15:20:56.000Z","date":"2026-07-31","kind":"exercise","planned":false,"acquired":true,"shares":11769,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":148539,"source":{"system":"sec-edgar","filing":"0001193125-26-329848","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329848/ownership.xml","form_type":"4"}},{"id":699416,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-03T14:59:50.000Z","date":"2026-07-31","kind":"exercise","planned":false,"acquired":false,"shares":11694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":116944,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11694},"source":{"system":"sec-edgar","filing":"0001193125-26-329804","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329804/ownership.xml","form_type":"4"}},{"id":699415,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-03T14:59:50.000Z","date":"2026-07-30","kind":"exercise","planned":false,"acquired":false,"shares":11769,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."}],"balance_after":164776,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11769},"source":{"system":"sec-edgar","filing":"0001193125-26-329804","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329804/ownership.xml","form_type":"4"}},{"id":699414,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-08-03T14:59:50.000Z","date":"2026-07-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":3326,"price":0.5,"value":1663.0,"ownership":{"direct":true},"balance_after":241173,"source":{"system":"sec-edgar","filing":"0001193125-26-329804","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329804/ownership.xml","form_type":"4"}},{"id":699413,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-08-03T14:59:50.000Z","date":"2026-07-31","kind":"exercise","planned":false,"acquired":true,"shares":11694,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":244499,"source":{"system":"sec-edgar","filing":"0001193125-26-329804","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329804/ownership.xml","form_type":"4"}},{"id":699412,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-08-03T14:59:50.000Z","date":"2026-07-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":3348,"price":0.5,"value":1674.0,"ownership":{"direct":true},"balance_after":232805,"source":{"system":"sec-edgar","filing":"0001193125-26-329804","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329804/ownership.xml","form_type":"4"}},{"id":699411,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-08-03T14:59:50.000Z","date":"2026-07-30","kind":"exercise","planned":false,"acquired":true,"shares":11769,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":236153,"source":{"system":"sec-edgar","filing":"0001193125-26-329804","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329804/ownership.xml","form_type":"4"}},{"id":699410,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-03T13:50:25.000Z","date":"2026-07-31","kind":"exercise","planned":false,"acquired":false,"shares":11694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":116944,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11694},"source":{"system":"sec-edgar","filing":"0001193125-26-329720","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329720/ownership.xml","form_type":"4"}},{"id":699409,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-03T13:50:25.000Z","date":"2026-07-30","kind":"exercise","planned":false,"acquired":false,"shares":13535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 216,562 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 216,562 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."}],"balance_after":189492,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13535},"source":{"system":"sec-edgar","filing":"0001193125-26-329720","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329720/ownership.xml","form_type":"4"}},{"id":699408,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-03T13:50:25.000Z","date":"2026-07-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":3326,"price":0.5,"value":1663.0,"ownership":{"direct":true},"balance_after":281899,"source":{"system":"sec-edgar","filing":"0001193125-26-329720","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329720/ownership.xml","form_type":"4"}},{"id":699407,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-03T13:50:25.000Z","date":"2026-07-31","kind":"exercise","planned":false,"acquired":true,"shares":11694,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":285225,"source":{"system":"sec-edgar","filing":"0001193125-26-329720","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329720/ownership.xml","form_type":"4"}},{"id":699406,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-03T13:50:25.000Z","date":"2026-07-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":3850,"price":0.5,"value":1925.0,"ownership":{"direct":true},"balance_after":273531,"source":{"system":"sec-edgar","filing":"0001193125-26-329720","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329720/ownership.xml","form_type":"4"}},{"id":699405,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-03T13:50:25.000Z","date":"2026-07-30","kind":"exercise","planned":false,"acquired":true,"shares":13535,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":277381,"source":{"system":"sec-edgar","filing":"0001193125-26-329720","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329720/ownership.xml","form_type":"4"}},{"id":699404,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-03T13:32:27.000Z","date":"2026-07-31","kind":"exercise","planned":false,"acquired":false,"shares":34789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":347886,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":34789},"source":{"system":"sec-edgar","filing":"0001193125-26-329694","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329694/ownership.xml","form_type":"4"}},{"id":699403,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-03T13:32:27.000Z","date":"2026-07-30","kind":"exercise","planned":false,"acquired":false,"shares":50021,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 800,337 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. The full amount of the RSUs granted to the Reporting Person is reflected herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 800,337 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. The full amount of the RSUs granted to the Reporting Person is reflected herein."}],"balance_after":700295,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":50021},"source":{"system":"sec-edgar","filing":"0001193125-26-329694","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329694/ownership.xml","form_type":"4"}},{"id":699402,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-03T13:32:27.000Z","date":"2026-07-31","kind":"exercise","planned":false,"acquired":true,"shares":34789,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":856492,"source":{"system":"sec-edgar","filing":"0001193125-26-329694","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329694/ownership.xml","form_type":"4"}},{"id":699401,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-03T13:32:27.000Z","date":"2026-07-30","kind":"exercise","planned":false,"acquired":true,"shares":50021,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":821703,"source":{"system":"sec-edgar","filing":"0001193125-26-329694","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329694/ownership.xml","form_type":"4"}},{"id":706068,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-07-20T20:22:52.000Z","date":"2026-07-19","kind":"exercise","planned":false,"acquired":false,"shares":13797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":82781,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13797},"source":{"system":"sec-edgar","filing":"0001193125-26-308958","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526308958/ownership.xml","form_type":"4"}},{"id":706067,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-20T20:22:52.000Z","date":"2026-07-19","kind":"exercise","planned":false,"acquired":true,"shares":13797,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":771682,"source":{"system":"sec-edgar","filing":"0001193125-26-308958","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526308958/ownership.xml","form_type":"4"}},{"id":706063,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-07-20T20:10:13.000Z","date":"2026-07-19","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":23246,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0001193125-26-308922","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526308922/ownership.xml","form_type":"4"}},{"id":706062,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-07-20T20:10:13.000Z","date":"2026-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":1101,"price":0.47,"value":517.47,"ownership":{"direct":true},"balance_after":224384,"source":{"system":"sec-edgar","filing":"0001193125-26-308922","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526308922/ownership.xml","form_type":"4"}},{"id":706061,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-07-20T20:10:13.000Z","date":"2026-07-19","kind":"exercise","planned":false,"acquired":true,"shares":3874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":225485,"source":{"system":"sec-edgar","filing":"0001193125-26-308922","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526308922/ownership.xml","form_type":"4"}},{"id":706066,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-07-20T19:54:21.000Z","date":"2026-07-19","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":23246,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0001193125-26-308887","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526308887/ownership.xml","form_type":"4"}},{"id":706065,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-20T19:54:21.000Z","date":"2026-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":1101,"price":0.47,"value":517.47,"ownership":{"direct":true},"balance_after":263846,"source":{"system":"sec-edgar","filing":"0001193125-26-308887","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526308887/ownership.xml","form_type":"4"}},{"id":706064,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-20T19:54:21.000Z","date":"2026-07-19","kind":"exercise","planned":false,"acquired":true,"shares":3874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":264947,"source":{"system":"sec-edgar","filing":"0001193125-26-308887","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526308887/ownership.xml","form_type":"4"}},{"id":735230,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-17T14:52:21.000Z","date":"2026-06-16","kind":"exercise","planned":false,"acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":12500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001193125-26-273552","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526273552/ownership.xml","form_type":"4"}},{"id":735229,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-17T14:52:21.000Z","date":"2026-06-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":3555,"price":0.38,"value":1350.9,"ownership":{"direct":true},"balance_after":261073,"source":{"system":"sec-edgar","filing":"0001193125-26-273552","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526273552/ownership.xml","form_type":"4"}},{"id":735228,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-17T14:52:21.000Z","date":"2026-06-16","kind":"exercise","planned":false,"acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":264628,"source":{"system":"sec-edgar","filing":"0001193125-26-273552","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526273552/ownership.xml","form_type":"4"}},{"id":747065,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-08T14:27:48.000Z","date":"2026-06-06","kind":"exercise","planned":false,"acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":12500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001193125-26-260931","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526260931/ownership.xml","form_type":"4"}},{"id":747064,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-06-08T14:27:48.000Z","date":"2026-06-06","kind":"exercise","planned":false,"acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":221611,"source":{"system":"sec-edgar","filing":"0001193125-26-260931","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526260931/ownership.xml","form_type":"4"}},{"id":789138,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":25235,"kind":"person","name":"Hensley Mark Earl","position":1,"cik":"0002065816","reported_name":"Hensley Mark Earl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-05-07T17:01:10.000Z","date":"2026-05-06","kind":"exercise","planned":false,"acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest with 25% upon the first anniversary of date of grant (May 6, 2025) and then in twelve (12) equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest with 25% upon the first anniversary of date of grant (May 6, 2025) and then in twelve (12) equal quarterly installments thereafter."}],"balance_after":375000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001193125-26-211230","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526211230/ownership.xml","form_type":"4"}},{"id":789137,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":25235,"kind":"person","name":"Hensley Mark Earl","position":1,"cik":"0002065816","reported_name":"Hensley Mark Earl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-07T17:01:10.000Z","date":"2026-05-06","kind":"exercise","planned":false,"acquired":true,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":136770,"source":{"system":"sec-edgar","filing":"0001193125-26-211230","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526211230/ownership.xml","form_type":"4"}},{"id":794661,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":25235,"kind":"person","name":"Hensley Mark Earl","position":1,"cik":"0002065816","reported_name":"Hensley Mark Earl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-05-04T16:49:09.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":false,"shares":11770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."}],"balance_after":176545,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11770},"source":{"system":"sec-edgar","filing":"0001193125-26-203374","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203374/ownership.xml","form_type":"4"}},{"id":794660,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":25235,"kind":"person","name":"Hensley Mark Earl","position":1,"cik":"0002065816","reported_name":"Hensley Mark Earl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-04T16:49:09.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":true,"shares":11770,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":11770,"source":{"system":"sec-edgar","filing":"0001193125-26-203374","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203374/ownership.xml","form_type":"4"}},{"id":794654,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-05-04T16:35:23.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":false,"shares":11770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."}],"balance_after":176545,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11770},"source":{"system":"sec-edgar","filing":"0001193125-26-203344","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203344/ownership.xml","form_type":"4"}},{"id":794653,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-05-04T16:35:23.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":false,"shares":11694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":128638,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11694},"source":{"system":"sec-edgar","filing":"0001193125-26-203344","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203344/ownership.xml","form_type":"4"}},{"id":794652,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-05-04T16:35:23.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":true,"shares":11770,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":209111,"source":{"system":"sec-edgar","filing":"0001193125-26-203344","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203344/ownership.xml","form_type":"4"}},{"id":794651,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-05-04T16:35:23.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":true,"shares":11694,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":197341,"source":{"system":"sec-edgar","filing":"0001193125-26-203344","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203344/ownership.xml","form_type":"4"}},{"id":794650,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-05-04T15:56:07.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":false,"shares":13535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 216,562 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 216,562 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."}],"balance_after":203027,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13535},"source":{"system":"sec-edgar","filing":"0001193125-26-203272","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203272/ownership.xml","form_type":"4"}},{"id":794649,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-05-04T15:56:07.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":false,"shares":11694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":128638,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11694},"source":{"system":"sec-edgar","filing":"0001193125-26-203272","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203272/ownership.xml","form_type":"4"}},{"id":794648,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-04T15:56:07.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":true,"shares":13535,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 11,023 shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2026."}],"balance_after":252128,"source":{"system":"sec-edgar","filing":"0001193125-26-203272","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203272/ownership.xml","form_type":"4"}},{"id":794647,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-04T15:56:07.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":true,"shares":11694,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":227570,"source":{"system":"sec-edgar","filing":"0001193125-26-203272","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203272/ownership.xml","form_type":"4"}},{"id":794646,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-05-04T15:30:39.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":false,"shares":50021,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 800,337 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 800,337 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."}],"balance_after":750316,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":50021},"source":{"system":"sec-edgar","filing":"0001193125-26-203196","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203196/ownership.xml","form_type":"4"}},{"id":794645,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-05-04T15:30:39.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":false,"shares":34789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":382675,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":34789},"source":{"system":"sec-edgar","filing":"0001193125-26-203196","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203196/ownership.xml","form_type":"4"}},{"id":794644,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-04T15:30:39.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":true,"shares":50021,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 11,023 shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2026."}],"balance_after":757885,"source":{"system":"sec-edgar","filing":"0001193125-26-203196","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203196/ownership.xml","form_type":"4"}},{"id":794643,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-04T15:30:39.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":true,"shares":34789,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":696841,"source":{"system":"sec-edgar","filing":"0001193125-26-203196","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203196/ownership.xml","form_type":"4"}},{"id":804003,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-04-21T15:15:26.000Z","date":"2026-04-19","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":27120,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0001193125-26-165591","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526165591/ownership.xml","form_type":"4"}},{"id":804002,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-04-21T15:15:26.000Z","date":"2026-04-19","kind":"exercise","planned":false,"acquired":true,"shares":3874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":185647,"source":{"system":"sec-edgar","filing":"0001193125-26-165591","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526165591/ownership.xml","form_type":"4"}},{"id":804001,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-04-21T13:41:20.000Z","date":"2026-04-19","kind":"exercise","planned":false,"acquired":false,"shares":13797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":96758,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13797},"source":{"system":"sec-edgar","filing":"0001193125-26-165365","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526165365/ownership.xml","form_type":"4"}},{"id":804000,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-21T13:41:20.000Z","date":"2026-04-19","kind":"exercise","planned":false,"acquired":true,"shares":13797,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":662052,"source":{"system":"sec-edgar","filing":"0001193125-26-165365","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526165365/ownership.xml","form_type":"4"}},{"id":803999,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-04-21T13:13:37.000Z","date":"2026-04-19","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":27120,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0001193125-26-165304","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526165304/ownership.xml","form_type":"4"}},{"id":803998,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-21T13:13:37.000Z","date":"2026-04-19","kind":"exercise","planned":false,"acquired":true,"shares":3874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 16,646 shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2025."}],"balance_after":215876,"source":{"system":"sec-edgar","filing":"0001193125-26-165304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526165304/ownership.xml","form_type":"4"}},{"id":814999,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-04-06T23:06:11.000Z","date":"2026-04-03","kind":"exercise","planned":false,"acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":62500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001193125-26-144196","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526144196/ownership.xml","form_type":"4"}},{"id":814998,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-06T23:06:11.000Z","date":"2026-04-03","kind":"exercise","planned":false,"acquired":true,"shares":62500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 14,045 shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2025."}],"balance_after":648255,"source":{"system":"sec-edgar","filing":"0001193125-26-144196","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526144196/ownership.xml","form_type":"4"}},{"id":923416,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Units","published_at":"2026-02-03T15:00:14.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":800336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Performance stock units (\"PSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 30, 2026, the Reporting Person was granted 800,336 PSUs which vest upon the following time-based vesting schedule: the PSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant, subject to satisfaction of the milestone-based vesting condition: the applicable percentage of the PSUs vesting based on a net product sales revenue target for the fiscal year ending December 31, 2026 as reported in the Issuer's Form 10-K. The full amount of the PSUs granted to the Reporting Person is reflected herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 30, 2026, the Reporting Person was granted 800,336 PSUs which vest upon the following time-based vesting schedule: the PSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant, subject to satisfaction of the milestone-based vesting condition: the applicable percentage of the PSUs vesting based on a net product sales revenue target for the fiscal year ending December 31, 2026 as reported in the Issuer's Form 10-K. The full amount of the PSUs granted to the Reporting Person is reflected herein."}],"balance_after":800336,"derivative":{"underlying":"Common Stock","underlying_shares":800336},"source":{"system":"sec-edgar","filing":"0001193125-26-034633","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034633/ownership.xml","form_type":"4"}},{"id":923415,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T15:00:14.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":800337,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 800,337 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. The full amount of the RSUs granted to the Reporting Person is reflected herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 800,337 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. The full amount of the RSUs granted to the Reporting Person is reflected herein."}],"balance_after":800337,"derivative":{"underlying":"Common Stock","underlying_shares":800337},"source":{"system":"sec-edgar","filing":"0001193125-26-034633","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034633/ownership.xml","form_type":"4"}},{"id":923414,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":19400,"kind":"person","name":"Christian Waage","position":1,"cik":"0001553179","reported_name":"Christian Waage","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-03T15:00:13.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":53960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in full on January 30, 2027. Each restricted stock unit represents a contigent right to receive one share of common stock."}],"balance_after":53960,"source":{"system":"sec-edgar","filing":"0001193125-26-034632","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034632/ownership.xml","form_type":"4"}},{"id":923413,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":30464,"kind":"person","name":"Kaseta Michael","position":1,"cik":"0001724346","reported_name":"Kaseta Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-03T15:00:11.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":53960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in full on January 30, 2027. Each restricted stock unit represents a contigent right to receive one share of common stock."}],"balance_after":53960,"source":{"system":"sec-edgar","filing":"0001193125-26-034631","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034631/ownership.xml","form_type":"4"}},{"id":923412,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Performance Stock Units","published_at":"2026-02-03T15:00:10.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":216561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Performance stock units (\"PSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 30, 2026, the Reporting Person was granted 216,561 PSUs which vest upon the following time-based vesting schedule: the PSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant, subject to satisfaction of the milestone-based vesting condition: the applicable percentage of the PSUs vesting based on a net product sales revenue target for the fiscal year ending December 31, 2026 as reported in the Issuer's Form 10-K. The full amount of the PSUs granted to the Reporting Person is reflected herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 30, 2026, the Reporting Person was granted 216,561 PSUs which vest upon the following time-based vesting schedule: the PSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant, subject to satisfaction of the milestone-based vesting condition: the applicable percentage of the PSUs vesting based on a net product sales revenue target for the fiscal year ending December 31, 2026 as reported in the Issuer's Form 10-K. The full amount of the PSUs granted to the Reporting Person is reflected herein."}],"balance_after":216561,"derivative":{"underlying":"Common Stock","underlying_shares":216561},"source":{"system":"sec-edgar","filing":"0001193125-26-034630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034630/ownership.xml","form_type":"4"}},{"id":923411,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T15:00:10.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":216562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 216,562 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. The full amount of the RSUs granted to the Reporting Person is reflected herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 216,562 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. The full amount of the RSUs granted to the Reporting Person is reflected herein."}],"balance_after":216562,"derivative":{"underlying":"Common Stock","underlying_shares":216562},"source":{"system":"sec-edgar","filing":"0001193125-26-034630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034630/ownership.xml","form_type":"4"}},{"id":923410,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":40405,"kind":"person","name":"Johnson Craig A","position":1,"cik":"0001370348","reported_name":"Johnson Craig A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-03T15:00:08.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":53960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in full on January 30, 2027. Each restricted stock unit represents a contigent right to receive one share of common stock."}],"balance_after":53960,"source":{"system":"sec-edgar","filing":"0001193125-26-034629","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034629/ownership.xml","form_type":"4"}},{"id":923409,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":68067,"kind":"person","name":"Cusack Thomas","position":1,"cik":"0002094824","reported_name":"Cusack Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-03T15:00:07.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":53960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in full on January 30, 2027. Each restricted stock unit represents a contigent right to receive one share of common stock."}],"balance_after":53960,"source":{"system":"sec-edgar","filing":"0001193125-26-034628","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034628/ownership.xml","form_type":"4"}},{"id":923408,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Performance Stock Units","published_at":"2026-02-03T15:00:05.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":188314,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Performance stock units (\"PSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 30, 2026, the Reporting Person was granted 188,314 PSUs which vest upon the following time-based vesting schedule: the PSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant, subject to satisfaction of the milestone-based vesting condition: the applicable percentage of the PSUs vesting based on a net product sales revenue target for the fiscal year ending December 31, 2026 as reported in the Issuer's Form 10-K. The full amount of the PSUs granted to the Reporting Person is reflected herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 30, 2026, the Reporting Person was granted 188,314 PSUs which vest upon the following time-based vesting schedule: the PSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant, subject to satisfaction of the milestone-based vesting condition: the applicable percentage of the PSUs vesting based on a net product sales revenue target for the fiscal year ending December 31, 2026 as reported in the Issuer's Form 10-K. The full amount of the PSUs granted to the Reporting Person is reflected herein."}],"balance_after":188314,"derivative":{"underlying":"Common Stock","underlying_shares":188314},"source":{"system":"sec-edgar","filing":"0001193125-26-034627","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034627/ownership.xml","form_type":"4"}},{"id":923407,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T15:00:05.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":188315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. The full amount of the RSUs granted to the Reporting Person is reflected herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. The full amount of the RSUs granted to the Reporting Person is reflected herein."}],"balance_after":188315,"derivative":{"underlying":"Common Stock","underlying_shares":188315},"source":{"system":"sec-edgar","filing":"0001193125-26-034627","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034627/ownership.xml","form_type":"4"}},{"id":923406,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":68066,"kind":"person","name":"Dissanaike Sharmila","position":1,"cik":"0001885069","reported_name":"Dissanaike Sharmila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-03T15:00:04.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":53960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in full on January 30, 2027. Each restricted stock unit represents a contigent right to receive one share of common stock."}],"balance_after":53960,"source":{"system":"sec-edgar","filing":"0001193125-26-034626","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034626/ownership.xml","form_type":"4"}},{"id":923405,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":25235,"kind":"person","name":"Hensley Mark Earl","position":1,"cik":"0002065816","reported_name":"Hensley Mark Earl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Performance Stock Units","published_at":"2026-02-03T15:00:03.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":188314,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Performance stock units (\"PSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 30, 2026, the Reporting Person was granted 188,314 PSUs which vest upon the following time-based vesting schedule: the PSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant, subject to satisfaction of the milestone-based vesting condition: the applicable percentage of the PSUs vesting based on a net product sales revenue target for the fiscal year ending December 31, 2026 as reported in the Issuer's Form 10-K. The full amount of the PSUs granted to the Reporting Person is reflected herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 30, 2026, the Reporting Person was granted 188,314 PSUs which vest upon the following time-based vesting schedule: the PSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant, subject to satisfaction of the milestone-based vesting condition: the applicable percentage of the PSUs vesting based on a net product sales revenue target for the fiscal year ending December 31, 2026 as reported in the Issuer's Form 10-K. The full amount of the PSUs granted to the Reporting Person is reflected herein."}],"balance_after":188314,"derivative":{"underlying":"Common Stock","underlying_shares":188314},"source":{"system":"sec-edgar","filing":"0001193125-26-034625","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034625/ownership.xml","form_type":"4"}},{"id":923404,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":25235,"kind":"person","name":"Hensley Mark Earl","position":1,"cik":"0002065816","reported_name":"Hensley Mark Earl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T15:00:03.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":188315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. The full amount of the RSUs granted to the Reporting Person is reflected herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. The full amount of the RSUs granted to the Reporting Person is reflected herein."}],"balance_after":188315,"derivative":{"underlying":"Common Stock","underlying_shares":188315},"source":{"system":"sec-edgar","filing":"0001193125-26-034625","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034625/ownership.xml","form_type":"4"}},{"id":923403,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":68065,"kind":"person","name":"Morgan Adam","position":1,"cik":"0001964335","reported_name":"Morgan Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-03T14:15:29.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":53960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in full on January 30, 2027. Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":123737,"source":{"system":"sec-edgar","filing":"0000921895-26-000200","document":"form412927018_02032026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000092189526000200/form412927018_02032026.xml","form_type":"4"}},{"id":923402,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T13:30:09.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":11695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":140332,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11695},"source":{"system":"sec-edgar","filing":"0001193125-26-034492","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034492/ownership.xml","form_type":"4"}},{"id":923401,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-03T13:30:09.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":11695,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":195356,"source":{"system":"sec-edgar","filing":"0001193125-26-034492","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034492/ownership.xml","form_type":"4"}},{"id":923400,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T13:30:07.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":11695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":140332,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11695},"source":{"system":"sec-edgar","filing":"0001193125-26-034491","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034491/ownership.xml","form_type":"4"}},{"id":923399,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-02-03T13:30:07.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":11695,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":181773,"source":{"system":"sec-edgar","filing":"0001193125-26-034491","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034491/ownership.xml","form_type":"4"}},{"id":923398,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T13:30:06.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":34789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":417464,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":34789},"source":{"system":"sec-edgar","filing":"0001193125-26-034490","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034490/ownership.xml","form_type":"4"}},{"id":923397,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-03T13:30:06.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":34789,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":571710,"source":{"system":"sec-edgar","filing":"0001193125-26-034490","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034490/ownership.xml","form_type":"4"}},{"id":936492,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-01-20T20:00:19.000Z","date":"2026-01-19","kind":"exercise","planned":false,"acquired":false,"shares":3875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":30994,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3875},"source":{"system":"sec-edgar","filing":"0001193125-26-016451","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526016451/ownership.xml","form_type":"4"}},{"id":936491,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-01-20T20:00:19.000Z","date":"2026-01-19","kind":"exercise","planned":false,"acquired":true,"shares":3875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":170078,"source":{"system":"sec-edgar","filing":"0001193125-26-016451","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526016451/ownership.xml","form_type":"4"}},{"id":936481,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-01-20T19:49:32.000Z","date":"2026-01-19","kind":"exercise","planned":false,"acquired":false,"shares":3875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":30994,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3875},"source":{"system":"sec-edgar","filing":"0001193125-26-016423","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526016423/ownership.xml","form_type":"4"}},{"id":936480,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-20T19:49:32.000Z","date":"2026-01-19","kind":"exercise","planned":false,"acquired":true,"shares":3875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":183661,"source":{"system":"sec-edgar","filing":"0001193125-26-016423","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526016423/ownership.xml","form_type":"4"}},{"id":936479,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-01-20T19:39:00.000Z","date":"2026-01-19","kind":"exercise","planned":false,"acquired":false,"shares":13797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":110375,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13797},"source":{"system":"sec-edgar","filing":"0001193125-26-016413","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526016413/ownership.xml","form_type":"4"}},{"id":936478,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-20T19:39:00.000Z","date":"2026-01-19","kind":"exercise","planned":false,"acquired":true,"shares":13797,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":536921,"source":{"system":"sec-edgar","filing":"0001193125-26-016413","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526016413/ownership.xml","form_type":"4"}},{"id":1003093,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":68067,"kind":"person","name":"Cusack Thomas","position":1,"cik":"0002094824","reported_name":"Cusack Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-12T14:20:31.000Z","date":"2025-11-08","kind":"grant","planned":false,"acquired":true,"shares":227272,"price":1.1,"value":249999.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options vest and become exercisable in 48 equal monthly installments beginning one month after the date of grant."}],"balance_after":227272,"derivative":{"exercise_price":1.1,"expiration_date":"2035-11-08","underlying":"Common Stock","underlying_shares":227272},"source":{"system":"sec-edgar","filing":"0001193125-25-276244","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525276244/ownership.xml","form_type":"4"}},{"id":1003092,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":68067,"kind":"person","name":"Cusack Thomas","position":1,"cik":"0002094824","reported_name":"Cusack Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-12T14:20:31.000Z","date":"2025-11-08","kind":"grant","planned":false,"acquired":true,"shares":37879,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares were granted as restricted stock units which vest in 16 equal quarterly installments beginning one quarter after the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":37879,"source":{"system":"sec-edgar","filing":"0001193125-25-276244","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525276244/ownership.xml","form_type":"4"}},{"id":1008963,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2025-11-04T17:35:32.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":false,"shares":11694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":152027,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11694},"source":{"system":"sec-edgar","filing":"0001193125-25-264044","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525264044/ownership.xml","form_type":"4"}},{"id":1008962,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-11-04T17:35:32.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":true,"shares":11694,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":166203,"source":{"system":"sec-edgar","filing":"0001193125-25-264044","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525264044/ownership.xml","form_type":"4"}},{"id":1008960,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-11-04T17:33:44.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":false,"shares":11694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":152027,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11694},"source":{"system":"sec-edgar","filing":"0001193125-25-264039","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525264039/ownership.xml","form_type":"4"}},{"id":1008959,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-04T17:33:44.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":true,"shares":11694,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":179786,"source":{"system":"sec-edgar","filing":"0001193125-25-264039","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525264039/ownership.xml","form_type":"4"}},{"id":1008958,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-11-04T17:31:27.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":false,"shares":34789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":452253,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":34789},"source":{"system":"sec-edgar","filing":"0001193125-25-264032","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525264032/ownership.xml","form_type":"4"}},{"id":1008957,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-04T17:31:27.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":true,"shares":34789,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":523124,"source":{"system":"sec-edgar","filing":"0001193125-25-264032","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525264032/ownership.xml","form_type":"4"}},{"id":1015583,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-21T15:56:25.000Z","date":"2025-10-19","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":34869,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0001193125-25-244582","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525244582/ownership.xml","form_type":"4"}},{"id":1015582,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-10-21T15:56:25.000Z","date":"2025-10-19","kind":"exercise","planned":false,"acquired":true,"shares":3874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":154509,"source":{"system":"sec-edgar","filing":"0001193125-25-244582","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525244582/ownership.xml","form_type":"4"}},{"id":1015580,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-21T15:42:43.000Z","date":"2025-10-19","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":34869,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0001193125-25-244560","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525244560/ownership.xml","form_type":"4"}},{"id":1015579,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-21T15:42:43.000Z","date":"2025-10-19","kind":"exercise","planned":false,"acquired":true,"shares":3874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":168092,"source":{"system":"sec-edgar","filing":"0001193125-25-244560","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525244560/ownership.xml","form_type":"4"}},{"id":1015578,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-21T15:23:26.000Z","date":"2025-10-19","kind":"exercise","planned":false,"acquired":false,"shares":13797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":124172,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13797},"source":{"system":"sec-edgar","filing":"0001193125-25-244520","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525244520/ownership.xml","form_type":"4"}},{"id":1015577,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27346,"kind":"person","name":"Collard Craig A","position":1,"cik":"0001363558","reported_name":"Collard Craig A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-21T15:23:26.000Z","date":"2025-10-19","kind":"exercise","planned":false,"acquired":true,"shares":13797,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":488335,"source":{"system":"sec-edgar","filing":"0001193125-25-244520","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525244520/ownership.xml","form_type":"4"}},{"id":1017270,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":74187,"kind":"organization","name":"Rubric Capital Management LP","position":1,"cik":"0001687509","reported_name":"Rubric Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74188,"kind":"person","name":"Rosen David Efraim","position":2,"cik":"0001898677","reported_name":"Rosen David Efraim","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock (\"Preferred Shares\")","published_at":"2025-10-17T22:00:57.000Z","date":"2025-10-15","kind":"exercise","planned":false,"acquired":false,"shares":94610,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Preferred Shares automatically converted into Common Stock pursuant to their terms at a conversion price of $1.50."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Preferred Shares automatically converted into Common Stock pursuant to their terms at a conversion price of $1.50."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Preferred Shares automatically converted into Common Stock pursuant to their terms at a conversion price of $1.50."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is filed by Rubric Capital Management LP (\"Rubric Capital\") and Mr. David Rosen, with respect to the securities held by certain funds and/or accounts (collectively, the \"Rubric Vehicles\"). Rubric Capital serves as the investment adviser to the Rubric Vehicles. Mr. David Rosen serves as the Managing Member of Rubric Capital Management GP, LLC, the general partner of Rubric Capital."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":946100},"source":{"system":"sec-edgar","filing":"0000902664-25-004459","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000090266425004459/ownership.xml","form_type":"4"}},{"id":1017269,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":74187,"kind":"organization","name":"Rubric Capital Management LP","position":1,"cik":"0001687509","reported_name":"Rubric Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74188,"kind":"person","name":"Rosen David Efraim","position":2,"cik":"0001898677","reported_name":"Rosen David Efraim","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.01 per share (\"Common Stock\")","published_at":"2025-10-17T22:00:57.000Z","date":"2025-10-15","kind":"exercise","planned":false,"acquired":true,"shares":946100,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Preferred Shares automatically converted into Common Stock pursuant to their terms at a conversion price of $1.50."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is filed by Rubric Capital Management LP (\"Rubric Capital\") and Mr. David Rosen, with respect to the securities held by certain funds and/or accounts (collectively, the \"Rubric Vehicles\"). Rubric Capital serves as the investment adviser to the Rubric Vehicles. Mr. David Rosen serves as the Managing Member of Rubric Capital Management GP, LLC, the general partner of Rubric Capital."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":30046828,"source":{"system":"sec-edgar","filing":"0000902664-25-004459","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000090266425004459/ownership.xml","form_type":"4"}}],"next_cursor":"2025-10-17T22:00:57.000000Z,1017269"}